Hansjakob Furrer
- Virology top 0.05%
- HIV Research and Treatment 99
- Infectious Diseases top 0.05%
- HIV/AIDS drug development and treatment 126
- HIV/AIDS Research and Interventions 113
- Tuberculosis Research and Epidemiology 30
- Emergency Medicine top 0.05%
- HIV-related health complications and treatments 61
- Hepatology top 0.5%
- Hepatitis C virus research 23
- Epidemiology top 0.2%
- Pneumocystis jirovecii pneumonia detection and treatment 53
- HIV, Drug Use, Sexual Risk 17
- Co-authors
- Enos BernasconiBernard HirschelPietro VernazzaAmalio TelentiManuel BattegayRainer WeberMatthias CavassiniBruno Ledergerber
- Partner nations
- SwitzerlandUnited KingdomUnited States
In The Last Decade
Hansjakob Furrer
271 papers receiving 13.8k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Virology 5.0k
- Infectious Diseases 9.2k
- Emergency Medicine 3.1k
- Hepatology 1.7k
- Epidemiology 5.6k
Countries citing papers authored by Hansjakob Furrer
This map shows the geographic impact of Hansjakob Furrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hansjakob Furrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hansjakob Furrer more than expected).
Fields of papers citing papers by Hansjakob Furrer
This network shows the impact of papers produced by Hansjakob Furrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hansjakob Furrer. The network helps show where Hansjakob Furrer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hansjakob Furrer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2022 | 10 | |
| 3 | 2022 | 0 | |
| 4 | 2021 | 79 | |
| 5 | 2021 | 2 | |
| 6 | 2021 | 11 | |
| 7 | 2021 | 6 | |
| 8 | 2021 | 2 | |
| 9 | 2020 | 8 | |
| 10 | 2020 | 10 | |
| 11 | 2018 | 13 | |
| 12 | 2017 | 86 | |
| 13 | 2016 | 39 | |
| 14 | Dynamic versus marginal structural models for estimating the effect of HAART on CD4 in observational studies : application to the Aquitaine Cohort study and the Swiss HIV Cohort Study | 2015 | 1 |
| 15 | 2014 | 34 | |
| 16 | 2010 | 60 | |
| 17 | 2006 | 17 | |
| 18 | 2006 | 11 | |
| 19 | 2005 | 170 | |
| 20 | 2002 | 95 |
About Hansjakob Furrer
Hansjakob Furrer is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 276 papers that have together received 14.3k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (126 papers), HIV/AIDS Research and Interventions (113 papers), HIV Research and Treatment (99 papers), HIV-related health complications and treatments (61 papers), Pneumocystis jirovecii pneumonia detection and treatment (53 papers), Tuberculosis Research and Epidemiology (30 papers), Hepatitis C virus research (23 papers) and HIV, Drug Use, Sexual Risk (17 papers). The work is most often cited by research in Virology (5.0k citations), Infectious Diseases (9.2k citations) and Emergency Medicine (3.1k citations). Hansjakob Furrer has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include Enos Bernasconi, Bernard Hirschel, Pietro Vernazza, Amalio Telenti, Manuel Battegay, Rainer Weber, Matthias Cavassini, Bruno Ledergerber, Matthias Egger and Martin Rickenbach. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.